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Abstract
Qureshi, Shahryar Jamshed. M.S. Department of Pharmacology and Toxicology, Wright
State University, 2018. Nanomaterial Charge-Dependent Platelet Activating Factor
Receptor Agonism in Human Epidermal Cells

Platelet Activating Factor (PAF) and its associated receptor, the PAF Receptor (PAFR),
are important mediators of intercellular communication during an immune response. Once
a physiological stimulus triggers an inflammatory response, epithelial, endothelial and
immune cells synthesize and release PAF. PAF mediates the recruitment of immune cells,
platelets, angiogenesis, expression of various genes, and increased PAF biosynthesis
(Brown, 2006; Han, 2006; Whatley, 1988; Axelrod, 1988). In this study, we utilized HaCaT
cells and a well characterized KB cell line derived from nasopharyngeal cells, which do
not natively express the PAFR. KB cells had previously been transfected with a PAF
receptor (KBP) or a mock transfection (KBM), yielding two cell lines. The KBM and KBP
cell lines allow for a mechanistic in vitro assessment of charge-dependent nanoparticle (NP)
mediated PAFR activation, where KBP cells should show more robust Interleukin-8 (IL-8)
secretion than KBM cells. Furthermore, this cell model serves to identify PAFR agonist
formation, which has been reported to be generated from cigarette smoke, ultraviolet B
radiation, jet fuel, and other stimuli that result in oxidative stress. The PAFR is involved in
clathrin-mediated endocytosis, yet the PAFR role in NP uptake has not been investigated.
The ability of NPs to generate PAF agonists is not known and the mechanisms by which
iii

they are internalized have yet to be fully understood. To investigate whether NP charge
contributes to direct PAF-like lipid formation, KBM, KBP and HaCaT cell lines were
exposed to 1 to 100µg/mL of 40nm Ag-NPs that were functionalized with either branched
polyethyleneimine (BPEI) or citrate to give them a positive or negative surface charge,
respectively. We demonstrated; a charge-dependent increase in NP-induced IL-8
production in KBP and HaCaT cells; indirectly measured an increased activation of the
PAFR after 24 hours of exposure in KBP and HaCaT cells; dose-dependent uptake of NPs
in all cell lines and increased reactive oxygen species (ROS) generation in KB cell lines
only. Further analysis of NP-induced PAFR activation may grant us a better understanding
of dermal inflammation and the potential role of PAF-like lipids in NP-mediated wound
healing therapies.
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Introduction
Engineered Nanomaterials (ENM) and nanoparticles (NPs) are variously shaped
and charged particles with on dimension that is less than 100 nanometers (nm). ENMs are
intentionally formed materials (tubes, wires, spheres, etc.) that are applied towards the
advancement of components and parts, known as nano-intermediates (coatings, textiles,
electronics, etc.). These nano-intermediates are incorporated into nano-enabled products
that surround us in our daily life and are utilized in many fields around the world today.
NPs are naturally or incidentally formed materials (diesel exhaust, welding fumes,
propellant exhaust, etc.) that sometimes are a result of ENM destruction (Ristovsky, 2006).
The global nanotechnology market has been increasing seeing a rise with every passing
year. The global nanocomposite market increased by $500 million USD between 2016 and
2017 (McWilliams, 2018), while the global nanomedical market increased by $17.5 billion
USD from 2016 to 2017 (Evers, 2018).
The boom of nanotechnology and use of nano-enabled products in our society has
driven the need to fully understand the potential toxicity of NPs. Nanotoxicology is the
study of the potential toxicity of ENMs and NPs based on their physical and chemical
properties. Investigating the implication of nano-scale particulate exposure is not only
important for human health effects, but also for environmental health effects. Numerous
studies have shown that ENMs and NPs toxic effects are dependent on their physical and
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chemical characteristics (size, shape, chemistry, crystal structure, solubility, surface
coating, surface charge, etc) (Posgai, 2011).
Nano-scale particulate exposure to the epithelium has been reported to cause
oxidative stress and acute inflammation (Zhang, 2008; Samberg, 2010; Yazdi, 2010).
Exposure to these particles can occur when one is in a combat environment, materials lab,
industrial facilities, or at home. The respiratory and integumentary systems are the most
probable routes of exposure, which is why it is important to understand the toxicological
mechanisms that takes place during these exposures. Not only can we better prevent disease
through understanding these mechanisms, we can also attempt to harness the ability of
these particles to elicit desired physiological outcomes.
The precise mechanism of NP-induced inflammation in the human epithelium is
not clear. To elucidate this mechanism, we investigate the involvement of the Platelet
Activating Factor Receptor (PAFR), a G-Protein Coupled Receptor (GPCR), primarily
expressed by endothelial, epithelial and immune cells (Whatley, 1989; McIntyre, 1987).
The PAFR binds its natural ligand, Platelet Activating Factor (1-O-alkyl-2-acetyl-snglycerolphosphocholine; PAF) a phospholipid autacoid, which activates the PAFR and
induces a potent paracrine cascade that mediates physiological and pathological conditions.
Upon activation, the PAFR elicits a cell-specific response dependent on the alpha
subunit isoform of its heterotrimeric G-protein complex (Brown, 2006). PAFR’s holding
the pertussis toxin (Ptx)-sensitive Gαi subunit cause an inhibition of Adenylate Cyclase
2

(AC) activity, preventing conversion of Adenosine Triphosphate (ATP) to Cyclic
Adenosine Monophosphate (cAMP). This inhibition also prevents the activation of the
[cAMP]-dependent enzyme, Protein Kinase A (PKA), which primarily regulates
carbohydrate and lipid metabolism (Brown, 2006; Ali, 1994; Ye, 1991). PAFR’s holding
the predominant, Ptx-insensitive, Gαq subunit activate Phospholipase C beta (PLCβ),
located in the inner membrane, which hydrolyzes the inner membrane protein
Phosphatidylinositol-4,5-bisphosphate (PIP2) into cytosolic Inositol-1,4,5-trisphosphate
(IP3) and membrane bound Diacylglycerol (DAG). IP3 diffuses across the cytoplasm to
bind to the Ins3P Receptor (Ins3PR), a glycoprotein receptor complex that acts as a ligandgated Ca2+ channel, located on the Endoplasmic Reticulum (ER) (Hirafuji, 1988). This
transient increase in intracellular Ca2+ propagates a myriad of cellular processes where Ca2+
acts as a second messenger (Barrett, 1984). In regards of the PAFR cascade, this Ca 2+
activates a group of calcium-dependent cytosolic Phospholipase A2 (cPLA2), which
translocates to the inner membrane to dock to PIP2 or Ceramide-1-phospate for membrane
binding and lipase activity (Six, 2003; Stahelin, 2007). Ca2+ also binds to Protein Kinase
C (PKC), which diffuses to the inner plasma membrane to bind DAG, completing its
activation (Kim, 2013). The PAFR downstream biological effects include platelet
aggregation, neutrophil chemotaxis, chemokine secretion, PAF biosynthesis, growth
signaling, cytoskeletal rearrangement, Reactive Oxygen Species (ROS) generation,
leukocyte activation and acute inflammation (Brown, 2006; Han, 2006; Whatley, 1988;
Axelrod, 1988).
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Due to PAF’s potent physiological activity at picomolar concentrations, the
understanding of regulated and unregulated PAF biosynthesis is important. The most
common natural isoforms of PAF have been identified as C16-PAF and C18-PAF, however
C16-PAF is the predominant molecular species in human epithelial and endothelial cells
(Holtzman, 1991). The glycerol backbone of PAF holds a 16:0 or 18:0 fatty acid at its sn1 position, a phosphatidylcholine moiety at its sn-3 position and an acetyl group, integral
for its function, at the sn-2 position (Marathe, 1999; Shen, 1987). Unlike most lipid
mediators, PAF uniquely undergoes a highly conserved ether linkage rather than an ester
linkage at its sn positions. The two-known regulated biosynthetic pathways responsible for
the generation of C16-PAF and C18-PAF are the remodeling pathway and the de novo
pathway. The remodeling pathway, which is the primary PAF biosynthetic pathway,
involves the removal of an unsaturated fatty acid (commonly 20:4) from the sn-2 position
of an ether glycerophosphocholine (GPC) by PLA2, yielding arachidonic acid and an ether
lyso-GPC (lyso-PAF). Lyso-PAF is acetylated by at the sn-2 position by Lyso-PAF
Acetyltransferase (LPCAT) and forms PAF. The de novo pathway utilizes a two to three
step enzymatic process that converts a 16:0 or 18:0 lyso-phospholipid into a 1-alkyl-2acetyl glycerol, which is used to generate PAF through the action of a phosphocholine
transferase enzyme (Flamand, 2009; Blank, 1987; Ramesha, 1986; Chilton, 1984). C 16PAF and C18-PAF are considered exclusive ligands to the PAFR and are regulated by the
enzyme PAF-Acetyl Hydrolase (PAF-AH). Outside of these regulated synthesis pathways,
there is ongoing investigation into the generation and effects of PAF-like lipids, capable of
4

acting as PAFR agonists. These PAF-like lipids have been identified as oxidized-GPCs
(OxGPC) which hold variation in length and saturation of their fatty acid tails, yet conserve
the acetyl and phosphatidylcholine groups at the sn-2 and sn-3 positions, respectively.
Factors such as Ultraviolet-B (UVB) radiation, cigarette smoke and lipoteichoic acid have
been reported as a few generators of OxGPCs through unregulated lipoxygenase-mediated
or free radical-mediated processes (Da Silva, 2017; Sahu, 2013; Yao, 2009; Travers, 1999).
A well-documented cellular response to silver (Ag) NP exposure is oxidative stress
(Shvedova, 2011; Foldbjerg, 2009; Carlson, 2007). The potential of charged Ag-NPs to
either directly oxidize GPCs, indirectly form OxGPCs through free radical generation or
activate the PAFR through interactions with the NP’s protein corona have not been
investigated. Ag NPs were used because of their increasing incorporation into biomedical,
consumer and wound healing products, as well as their well-known antibacterial properties
(Dunn, 2004; Khundkar, 2009). In this study, we utilized two well characterized
nasopharyngeal cell lines (KB) that either received a stable transfection of the PAFR (KBP)
or a mock transfection (KBM). We also utilized the immortalized human keratinocyte
HaCaT cells line which endogenously expresses the PAFR. We investigated the potential
of positively and negatively charged Ag-NPs to form PAF-like lipids in KBM, KBP and
HaCaT cells. The aims of this study were to understand: the role of Ag-NP charge in PAFR
activation and PAF-like lipid formation in KBM, KBP and HaCaT cells; the role of ROS
in the inflammation response to charged Ag-NPs exposure in KBM, KBP and HaCaT cells;
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and the endocytic potential of PAFR-positive and negative cells during charged Ag-NP
exposure.

Physiologic stimulus/
Pathologic trigger

PAF

Charged NPs

Lipids

PAF
PAF
Receptor

PAF
Receptor

Inflammatory Mechanism
Ca2+

PLA2

Nanoparticle Dependent
Mechanism
IL-8

PKC

ERK1/2

Figure 1. Hypothesized mechanism of NP-dependent formation of PAF-like lipids.
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Methods and Materials
Materials and Reagents
40nm Ag-Branched Polyethyleneimine (BPEI) and 40nm Ag-Citrate nanoparticles
were obtained from NanoComposix (San Diego, CA). N-Acetyl-Cysteine (NAC) and
tetradecanoyl phorbol acetate (TPA) was obtained from Sigma-Aldrich (Saint Louis, MO).
DMEM High Glucose media, heat inactivated Fetal Bovine Serum (HI-FBS),
penicillin/streptomycin (P/S), Hanks Balanced Salt Solution (HBSS), Bovine Serum
Albumin (BSA) and 0.25% Trypsin-EDTA were all acquired from Gibco inc.
(ThermoFisher Scientific, USA). The PAFR agonist used in these studies was CarbamoylPAF (CPAF; 1-hexadecyl-2-N-methylcarbamoyl glycerophosphocholine) which was
purchased from Cayman Chemical (MI, USA).
Dynamic Light Scattering (DLS)
Nanoparticles hydrodynamic diameter and surface charge (zeta potential) were
determined by analyzing a 100ug/mL solution of NPs suspended in H2O, HBSS or
supplemented media in disposable cuvettes with a Zetasizer Nano ZS (Malvern Instruments,
Malvern, UK).
Cell Culture
KBM and KBP cells were kindly provided by Dr. Jeffrey Travers (Pharmacology
and Toxicology Department, Boonshoft School of Medicine, Wright State University, OH,
USA) and HaCaT cells were purchased from ATCC (Manassas, VA). KBM, KBP and
7

HaCaT cell lines were cultured in DMEM high glucose medium in individual T-75 flasks
and incubated at 37°C in a 5% CO2 atmosphere. DMEM media was supplemented with 10%
HI-FBS, 1% P/S and 1% L-Glutamine. KBM, KBP and HaCaT cells were seeded
individually into 48-well plates at 40,000cells/cm2. Cells were trypsinized with 0.25%
EDTA-free Trypsin once at 80% confluency and a cell count was determined using a
Cellometer Vision (Nexcelom Bioscience, Lawrence, MA). Once seeded, cells were
incubated for 24 hours for maximum adherence before experimental exposure.
Upon 24-hour exposure to nanoparticles, supernatant was collected and stored at
4°C for IL-8 quantification. Cells in each well were washed twice with 1xPBS (200µL),
trypsinized (100µL) and neutralized with HI-FBS containing media (200µL) for flow
cytometry. The remaining cells were stored at 4°C in 15mL conical tubes for uptake
analysis.
Flow Cytometry
A Guava 12-HT Easycyte Flow cytometer (EMD Millipore-Sigma, USA) was used
to determine cell count. 48-well plates were spun down at 600 rcf (relative centripetal force)
using a plate centrifuge to pellet the non-adherent (dead) cell fraction. The exposure media
was then aspirated and rinsed twice with 1xPBS, with a plate centrifuge step before each
aspiration. Cells were then trypsinized and subsequently neutralized after 5 minutes at
37°C in a 5% CO2 atmosphere. 60µL of the live and dead cell fractions of each well were
placed in a U-bottom 96-well plate (EMD Millipore-Sigma, USA) and was followed with
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60µL of Guava Viacount solution (EMD Millipore-Sigma, USA) and incubated at 37°C in
a 5% CO2 atmosphere for 5 minutes. The Guava flow cytometer was flushed, primed and
gated prior to running the plate. Following incubation, the 96-well plate was loaded into
the cytometer with the blue laser with PM1 voltage of 450, PM2 voltage set to 550.
Inductively Coupled Plasma – Mass Spectrometry (ICP-MS) Sample Preparation
A NexION 300D (Perkin Elmer) was utilized to quantify the uptake of
nanoparticles. The remaining volume of live and dead cell fractions in the 48-well plates
that were not used for flow cytometry were placed into individual 15mL conical tubes and
prepared for ICP-MS analysis. Organic content was dissolved in concentrated HCl (37%),
HNO3 (60%) and diluted Triton-X 100 (1%), reagents were added at 8.1%, 1.4%, and 5.0%
of the total 10mL ICP-MS sample volume. Bismuth was used as an internal standard and
added at 2% of ICP-MS sample volume. Samples were incubated for 30 minutes to ensure
all organic material was dissolved before running through a NexION 300D.
IL-8 Analysis
IL-8 secretion was quantified via an enzyme linked immunosorbent assay (ELISA;
Human IL-8 ELISA MAX Deluxe Kit, Biolegend Inc., USA) according to the provided
instructions. ELISA plates were read using a Flexstation 3 Plate Reader (Molecular
Devices LLC, San Jose, USA) at an absorbance of 450nm and the obtained values were
standardized by normalizing to total cell count.
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Reactive Oxygen Species (ROS) Analysis
ROS was analyzed using a 5mM dichlorofluorescin diacetate (H2DCF-DA) probe
incubated for 30 minutes in 96-well cell culture plates prior to NP exposure. After exposure,
fluorescence was read using a Flexstation 3 Plate Reader measured at a wavelength of
480nm at 0, 2, 4, 6, 8 and 24 hours. H2O2 was used as a positive control in each experiment
to control for probe reactivity and NAC was used as a negative control in each experiment
to control for ROS-mediated probe reactivity.
PAF-R Immunostaining and Confocal Imaging
KBM and KBP cells were imaged for PAFR protein expression through
fluorescence microscopy using an Olympus IX81 Confocal Laser Scanning Microscope
(Olympus Inc., USA). Cells were stained for the PAFR using an Anti-PAF Receptor
antibody (ab104162; Abcam plc., USA), actin was stained or using Alexafluor phalloidin
488 actin stain (1:100 dilution; Invitrogen, USA) and DNA was stained using DAPI stain
(1:1500 dilution). KBM and KBP cells were seeded on a round glass substrate placed
within a 12-well plate. Cells were first fixed in paraformaldehyde (4%) for 5 minutes,
followed by washing with PBS. Cell membranes were then permeabilized using Triton-X
100 (0.1%) for 15 minutes at 37 degrees Celsius, subsequently washed with PBS, and
blocked using BSA (1%) for 30 minutes. Cells were then incubated in Anti-PAFR antibody
(1:1000) overnight. After overnight incubation the antibody was aspirated and washed
three times with 1x PBS for five minutes each. The secondary antibody, Alexa Fluor 568
(ab175471; 1:1000; Abcam plc., USA) was incubated for one hour at room temperature
10

and subsequently washed three times with 1xPBS for 5 minutes each. After secondary
antibody incubation, DAPI and Alexafluor 488 phalloidin stain was applied for 30 minutes.
After staining, cells were washed three times with 1xPBS, coated with a drop of Prolong
Gold mounting media (Invitrogen, USA), and secured to a glass coverslip. The next day,
excess mounting media was removed, and the edges of the sample were sealed with clear
finger nail polish. Images were then taken using a UPLFLN 40x Oil objective with a
numerical aperture of 1.3. The laser settings are as follows: 405nm set at 15% and 450
volts; 488nm set at 25% and 510 volts; 543nm set at 30% and 685 volts.
Transmission Electron Microscopy (TEM)
Cell samples were fixed in 2% paraformaldehyde (Electron Microscopy Supplies,
USA) and 2.5% glutaraldehyde (Electron Microscopy Supplies, USA) for 15 min. at room
temperature, and subsequently stained with 1% osmium tetroxide (Electron Microscopy
Supplies, USA) for 1 hour. Serial dehydrations were performed with 30%, 70%, 95%, and
100% ethanol. Following dehydration, samples were placed in a 1:1 ratio of 100% ethanol
and LR White resin for 1 hour at room temperature, then into 100% LR White resin
(Electron Microscopy Supplies, USA) and cured overnight at 60°C and -25psi. Cured
blocks were sectioned using a Leica Ultramicrotome UC7 (Leica Inc., USA), and 70nm
sections were deposited onto copper grids with carbon film. Imaging and elemental
analysis was performed on the Zeiss Gemini STEM (Zeiss, USA).
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Results
Characterization of 40nm Ag-BPEI and 40nm Ag-Citrate NPs and KB Cell Lines
The hydrodynamic diameter, surface charge (ζ-potential) and polydispersity index
(PDI) of Ag-NPs are displayed in Table 1. The desired ζ-potential of NPs in solution was
only attained when using HBSS as the vehicle, with Ag-BPEI NPs holding a positive
charge of 22.2 ± 0.417mV and Ag-Citrate NPs holding a negative charge of -30.5 ±
3.16mV. TEM images of 40nm Ag-BPEI and 40nm Ag-Citrate NP, as engineered, are
shown in Figure 2, with their respective surface functionality’s chemical structure.

40nm Ag-BPEI
Water
40nm Ag-Citrate
40nm Ag-BPEI

DH

ζ-Potential

PDI

(Mean SEM)

(Mean SEM)

(Mean SEM nm)

45.81
0.877
43.33
0.744
201

34.7

0.611

0.159

0.002

-37.8

0.371

0.132

0.001

0.881

-8

1.40

0.191

0.008

1.1

-11

0.12

0.27

0.003

22.2

0.417

0.252

0.003

-30.5

3.16

0.253

0.01

Media
40nm Ag-Citrate

40nm Ag-BPEI
HBSS
40nm Ag-Citrate

112.5

88.36
1.47
287.3
13.8

Table 1. The hydrodynamic diameter (DH), surface charge (ζ -potential; mV) and polydispersity index (PDI) of 40nm AgBPEI and 40nm Ag-Citrate in water, DMEM media and HBSS.

KBM and KBP cell lines were stained for the PAFR, actin and nucleus at normal
conditions to confirm the stable expression of the PAFR. In Figure 3, confocal images
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show membrane localization and qualitative confirmation of the expression of the PAFR
in, PAFR-positive, KBP cells but not in, PAFR-negative, KBM cells. We also observed no
difference between morphology of the two cell lines

a.

b.

c.

d.

Figure 2. TEM images of 40nm Ag-BPEI (a) and 40nm Ag-Citrate NPs as engineered. The surface functionalization and
chemical structure of branched polyethyleneimine (c) and citrate (d) are also provided. (Images taken from
Nanocomposix)
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Figure 3. Confocal images of KBM and KBP cells stained for the PAFR (red), actin (green) and nucleus (blue).

Dose-Dependent IL-8 Secretion in PAFR Transfected Cells 24 Hours Post-Exposure to
Charged Ag-NPs
IL-8 secretion was used as a direct indicator of inflammation as well as an indirect
indicator of PAFR activation. PAFR-negative KBM cells showed no significant increase
in IL-8 secretion in response to positively or negatively charged Ag-NPs at 1, 2.5, 5, 10
and 100µg/mL (Figure 4a). We observed a significant dose-dependent increase in IL-8
secretion in PAFR-positive KBP cells 24 hours post-exposure to 5 and 10µg/mL
concentrations of positively charged Ag-BPEI NPs, yet this effect was not seen in response
14

to negatively charged Ag-Citrate NPs (Figure 4b). As expected, KBM and KBP cells
showed significant secretions of IL-8 in response to 100nM of TPA, however only KBP
cells responded to 100nM of the PAFR agonist, CPAF. Interestingly, we observed that
concurrent 10µg/mL Ag-NP treatment with CPAF led to a suppression of IL-8 secretion
and PAFR activation. Concurrent Ag-BPEI/CPAF exposure brought IL-8 secretion levels
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to non-significant levels (Figure 4b), whereas concurrent Ag-Citrate/CPAF exposure
significantly suppressed IL-8 secretions when compared to CPAF exposure.

a.

KBMock Cells
400
300

40nm
Ag-BPEI
Ag-BPEI+

200

40nm
Ag-Citrate
Ag-Citrate-

#

#

pg IL-8/105 Cells

100
80
60

40

20
0

b.

KBPAFR Cells

400
300

40nm
Ag-BPEI
Ag-BPEI+

200

40nm
Ag-Citrate
Ag-Citrate-

pg IL-8/105 Cells

100
80

#

#

#

#

60

40

*

*

**

20
0

Treatment ( mg/mL)

Figure 4. IL-8 secretion 24 hours post-exopsure to 40nm Ag-BPEI and 40nm Ag-Citrate NPs in KBM (a) and KBP (b)
cells. All treatments were compared to the 0 control within groups using a one-way ANOVA (Dunnets test; mean ± SEM,
n=3 experiments; p<0.05 = *; p<0.01 = **; p<0.0001 = #)
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PAFR-Dependent IL-8 Secretion During Positively Charged Ag-NP Exposure
We compared the IL-8 secretion 24 hours post-exposure and found that the KBP
cells secreted significantly higher levels of IL-8 than KBM cells during exposure to AgBPEI NPs but not to Ag-Citrate NPs (Figure 5a). Ag-BPEI NPs elicited significantly higher
IL-8 secretion in KBP cells at 5 and 10µg/mL dosages whereas Ag-Citrate NPs elicited
significantly higher IL-8 secretions in KBP cells during 10µg/mL/CPAF exposure in KBP
cells (Figure 5b). In Figure 5a, we see a full suppressive effect of IL-8 secretion during
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concurrent exposure of 10µg/mL Ag-BPEI and CPAF. This effect also exists in during
concurrent Ag-Citrate and CPAF exposure, but to a lesser extent (Figure 5).
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Figure 5. IL-8 secretion 24 hours post-exopsure to 40nm Ag-BPEI (a) and 40nm Ag-Citrate (b) NPs in KBM and KBP
cells. All treatments were compared between groups using a two-way ANOVA (Bonferroni test; mean ± SEM, n=3
experiments; p<0.05 = *; p<0.01 = **; p<0.0001 = #)
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PAFR-Dependent ROS Generation During Charged Ag-NP Exposure in Nasopharyngeal
Cells
To investigate the magnified NP-induced inflammation in KBP cells, we analyzed
ROS generation from 0 to 24 hours post-exposure to a 10µg/mL dose of NPs in KBM and
KBP cells. In KBM cells, significant ROS generation was only seen at 2 hours postexposure to Ag-BPEI NPs and at 8 and 24 hours post-exposure to Ag-Citrate NPs (Figure
6). In KBP cells, we found sustained ROS generation when exposed to Ag-BPEI from 2 to

24 hours post-exposure and significant ROS generation to Ag-Citrate NPs beginning from
4 to 24 hours post-exposure (Figure 6). We witnessed a sharp increase of ROS generation
in response to Ag-Citrate NPs starting at 8 hours post-exposure in KBM cells and at 6 hours
post-exposure in KBP cells. Both KBM and KBP cells exposed to Ag-BPEI saw a transient
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elevation of ROS followed by a quick drop off seen at 2 hours in KBM cells and 4 hours
in KBP cells (Figure 6).
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Figure 6. ROS generation in KBM (a) and KBP (b) cells exposed to 100nM CPAF, 10µg/mL Ag-BPEI, 10µg/mL AgCitrate, 100uM H2O2 or 5mM NAC solution. Data is represented as fold change from the untreated control from each
hour. All treatments were compared to the 0-hour reading within treatment groups using a one-way ANOVA (Dunnets
test; mean ± SEM, n=3 experiments; p<0.05 = *; p<0.01 = **; p<0.0001 = #)
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Cell Line Dependence of IL-8 and ROS generation
To confirm PAFR involvement during charged Ag-NP exposure, we utilized
human keratinocyte HaCaT cells, which endogenously expresses the PAFR. As expected,
we found significant IL-8 secretion during 100nM CPAF exposure. Significant IL-8
secretion was only seen at the 10µg/mL Ag-BPEI exposure, however no significant IL-8
secretion was seen at any concentration during Ag-Citrate exposure (Figure 7). There was
a significant and familiar suppression of IL-8 during concurrent 100nM CPAF and
10µg/mL Ag-BPEI and Ag-Citrate treatments (Figure 7). HaCaT cells showed significant
ROS generation to CPAF exposure at 2 hours and to 10µg/mL Ag-Citrate at 24 hours, yet
showed no significant ROS generation to 10µg/mL Ag-BPEI exposure (Figure 8).
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Figure 7. IL-8 secretion 24 hours post-exopsure to 40nm Ag-BPEI and 40nm Ag-Citrate NPs in HaCaT cells. All
treatments were compared to the 0 control within NP groups using a one-way ANOVA (Dunnets test; mean ± SEM, n=3
experiments; p<0.05 = *; p<0.01 = **)
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Figure 8. ROS generation in HaCaT cells exposed to 100nM CPAF, 10µg/mL Ag-BPEI, 10µg/mL Ag-Citrate, 100uM
H2O2 or 5mM NAC solution. Data is represented as fold change from the untreated control from each hour. All treatments
were compared to the 0 hour reading within treatment groups using a one-way ANOVA (Dunnets test; mean ± SEM,
n=3 experiments; p<0.05 = *; p<0.0001 = #)
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PAFR-Independent Uptake of Charged Ag-NPs at 24 Hours Post-Exposure
To further investigate the role of the PAFR in charged NP-induced inflammation,
we measured charged Ag-NP uptake in KBM, KBP and HaCaT cell lines. ICP-MS results
indicated a PAFR-independent endocytic potential of KBM, KBP and HaCaT cells 24
hours post-exposure. A dose-dependent internalization of Ag ions was detected in all cell
types at all dosages, with significant internalization at the 100µg/mL dosages. No
significant difference of Ag-NP internalization was detected between cell types
(comparison not shown). To confirm the PAFR-independent uptake of Ag-NPs, KBM cells
were exposed to 10µg/mL Ag-BPEI, fixed and prepared for TEM imaging. In Figure 10,
we see internalized Ag-NPs contained in vesicles within KBM cells 8 hours post-exposure.
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Figure 9. ICP-MS data showing internalized concentration of Ag ions per 100,000 cells for KBM (a), KBP (a) and
HaCaT (b) cells. All treatments were compared to the 0 control within groups using a two-way ANOVA (Bonferonni test;
mean ± SEM, n=3 experiments; p<0.01 = **)
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Figure 10. TEM image of KBM cell exposed to 10µg/mL Ag-BPEI NPs for 8 hours.
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Discussion
The role of the PAFR in NP-mediated inflammation has not been investigated in
the past, yet it has been extensively reported that exposure of charged and neutral nanoscale particulate to human keratinocytes leads to oxidative stress and inflammation
(Samberg, 2010; Schaeublin, 2010; Miura, 2009). We wanted to investigate whether
charged NPs are directly (Ag ion-mediated/protein corona-mediated lipid peroxidation) or
indirectly (ROS-mediated lipid peroxidation) involved in the phenomenon of PAF-like
lipid formation. To study this agonist formation, we utilized a unique model system to
study PAFR activation. This system utilized KB, human nasopharyngeal, cells that do not
express the PAFR in their native form. A group of KB cells were transduced with PAFR
cDNA and the other group was transduced with control cDNA to yield PAFR-positive KBP
cells and PAFR-negative KBM cells (Figure 3). The KB-PAFR model system is an
excellent model to use when studying PAF-like lipid formation because of the model’s use
of a downstream effect of PAFR activation in epithelial cells, IL-8 secretion, which
promotes the recruitment of neutrophils to the site of inflammation (Jeon, 2002). Thus, we
measured and utilized IL-8 concentrations from the supernatant of exposed cell cultures as
a surrogate of PAFR agonist activity (Figure 11). Another downstream effect of PAFR
activation is the production of ROS, which we also utilized as an indirect measure of PAFR
activation.
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Figure 11. The KB-PAFR model system. (Image courtesy of Dr. Jeffrey Travers)

During characterization of the Ag-BPEI and Ag-Citrate NPs, we aimed to keep the
NPs respective surface charge intact. When in DMEM high glucose medium supplemented
with 1, 5 or 10% FBS, Ag-BPEI NPs lost their positive surface charge, presumably due to
proteins from the FBS coating the NPs (Data not shown). To amend this, we utilized HBSS
as the exposure medium, which allowed both NPs to maintain their respective surface
charge (Table 1). HBSS is a Ca2+/Mg2+-containing isotonic salt solution which provides no
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nutrition for cells and may have skewed cell viability after 24 hours. Since we were not
interested in charged NP cytotoxicity, we focused on the ability of charged NPs to illicit
the formation of PAF-like lipids. Using Ag NPs in this study did pose challenges due to
their toxic potential making it difficult when discerning the effect of charge in PAFR
activation.
Due to the potency of PAF, low levels of unregulated PAF-like lipid formation can
lead to toxicity in the form of chronic inflammation. In this mechanistic study, we show
support for positively charged 40nm Ag-BPEI NPs directly causing PAF-like lipid
formation from the significant increase of IL-8 secretion seen at a 10µg/mL dose 24 hours
post-exposure in PAFR-positive KBP cells, but not in PAFR-negative KBM cells (Figure
4). This direct agonist formation and subsequent PAFR activation also yielded significant
ROS generation at 24 hours post-exposure in KBP cells, but not in KBM cells (Figure 6).
We also show support for the direct formation of PAF-like lipids in KBP cells from the,
sustained, significant ROS generation from 2 to 24 hours post-exposure to Ag-BPEI NPs,
whereas KBM cells did not show significant ROS generation after 2 hours (Figure 6).
To confirm the direct formation of PAF-like lipids in PAFR-positive cells, we next
utilized HaCaT, human keratinocyte, cells that endogenously express the PAFR. HaCaT
cells, like KBP cells, showed significant IL-8 secretion during exposure to 10µg/mL AgBPEI NPs at 24-hours (Figure 7), however there was no significant ROS generation seen
in HaCaT cells from 2 to 24 hours post-exposure to Ag-BPEI NPs (Figure 8). These results
may indicate a cell type-dependent response to PAF-like lipid formation based on variation
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in GPC abundance in the plasma membrane or antioxidant enzyme activity between KB
(nasopharyngeal) and HaCaT (keratinocyte) cells. There was significant ROS generation
at 24 hours post-exposure to 10µg/mL Ag-Citrate NP exposure in HaCaT cells (Figure 8),
which was also seen in KBM and KBP cells (Figure 6). This effect is attributed to a higher
loss of mitochondrial membrane potential and apoptosis in response to negatively charged
NPs being endocytosed and transferred to lysosomes more readily than positively charged
NPs (Tomita, 2011). The DCF-DA probe was confirmed as functional from the hydrogen
peroxide treatment and the HaCaT cell’s PAFR was also shown as functional from its
response to 100nM CPAF (Figure 7; Figure 8).
Significant ROS generation was shown during 100nM CPAF exposure in KBP and
HaCaT cells 2 hours post-exposure and was followed by a decline of ROS generation
(Figure 6; Figure 8). This effect is attributed to homogenous desensitization which inhibits
PAFR signaling after abundant receptor activation (Ali, 1999). The elevated ROS
generation in KBM cells in response to 100nM CPAF was surprising (Figure 6), however
this oxidative stress took place through a PAFR-independent mechanism since there was
no significant IL-8 secretion from KBM cells in response to 100nM CPAF exposure and
homologous desensitization was not observed (Figure 4a; Figure 6a). Interestingly, we
demonstrated an inhibitory effect on CPAF-induced IL-8 secretion by charged Ag NPs.
All cell lines were exposed to 100nM CPAF and 10µg/mL Ag-BPEI or Ag-Citrate NPs, at
a zero point of addition. At 24 hours post-exposure, we displayed an inhibition of IL-8
secretion in KBP and HaCaT cells during CPAF-induced PAFR activation in the presence
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of 10µg/mL Ag-BPEI NPs (Figure 4b; Figure 7). 10µg/mL Ag-Citrate NPs also
significantly reduced CPAF-induced IL-8 secretion, but not as much as Ag-BPEI in KBP
and HaCaT cells (Figure 5; Figure 7). This anti-inflammatory effect of charged NPs has
been reported before in lipopolysaccharide-induced cytokine production in macrophage
(raw264.7) cells (Tomita, 2011), however more research needs to be done to understand
the mechanism behind this phenomenon.
To further elucidate the inconsistency in ROS generation between KBP and HaCaT
cells, we analyzed the uptake dynamics of the cell lines when exposed to Ag-BPEI and AgCitrate NPs. We display a PAFR-independent endocytic potential of charged Ag-NPs in
epidermal cells (Figure 10). Significant uptake of charged Ag-NPs was shown during the
100 µg/mL exposures in KBM, KBP and HaCaT cells 24 hours post-exposure (Figure 9).
Our data supports previously reported ICP-MS results of Ag-NP internalization in
fibroblast cells (Wildt, 2016). There was no difference between uptake between any of the
cell lines or between NP types within the cell lines, however kinetic differences have been
reported in the past between cationic and anionic NPs. Positively-charged NPs have been
shown to be endocytosed through non-specific, adsorptive micropinocytosis and to adhere
to the negative cell surface of the inner leaflet of the cells plasma membrane (Ono, 1986;
Lunov, 2011). This form of endocytosis is clathrin-mediated and once the endosome is
internalized, the clathrin coat is lost and recycled into the plasma membrane, while the NPs
are within the cell. Kim et al. and Park et al., have shown that polyethyleneiminefunctionalized NPs are able to enter the nucleus of the cell and be used to deliver genes as
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a non-viral vector (Park, 2010; Kim, 2011) while Ag-BPEI NPs have also been shown to
enter the nucleus (Pang, 2015). Depending on the size and surface characteristics of NPs,
they will eventually be taken up by lysosomes are dissolved into ions, which causes ROS
generation, cytotoxicity and genotoxicity (Asharani, 2009; Cronholm, 2013; Gliga, 2014;
Pang, 2015). Furthermore, studies report that negatively-charged NPs are phagocytosed
rather than endocytosed due to gram-negative bacteria also holding a negative charge,
however they are also endocytosed through clathrin and dynamin-mediated endocytosis
(Ono, 1986; Marshal, 1971; Lunov, 2011). The phagocytosed negatively-charged NPs are
internalized, delivered to lysosomes and dissolved into ions. The lysosomal dissolution of
Ag-NPs in our study does make it difficult to decipher the role of charge in the direct
formation of PAF-like lipids from the cytotoxicity that arises from Ag ion leakage inside
of the cell. The difference in uptake, distribution and temporal fate may account for the
differences we observe in IL-8 secretion and ROS generation between positively and
negatively-charged Ag NP exposure.
In the current study, we hypothesize a novel, ROS-independent, pathway of the
formation of PAF-like lipids, that act as PAFR agonists, from plasma membrane lipid
interactions with amine functionalized Ag-NPs (Figure 1). We postulate that Ag-BPEI NPs
interact with the outer and inner leaflet of the plasma membrane, intracellular proteins,
organelles and the nucleus once inside of epidermal cells. Once positively-charged NPs
cluster at the outer and inner leaflet of the plasma membrane, they cause lipid peroxidation
of GPC and form OxGPCs, which activate the PAFR’s inflammatory cascade. With more
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investigation into direct PAF-like lipid formation from NP exposure, we may harness the
ability to form PAFR agonists and remotely induce inflammatory states, which may
advance current wound healing therapies.
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Table 2. Summary of ROS generation, IL-8 secretion and Ag-NP uptake in KBM, KBP and HaCaT cells during exposure
to Ag-BPEI and Ag-Citrate NPs.
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Figure 12. PAF synthesis pathways. Pathway 1 shows the remodeling pathway. Pathway 2 shows the de novo pathway.
Pathway 3 shows the lipid peroxidation pathway. Pathway 4 shows our hypothesized NP-mediated pathway of PAF-like
lipid synthesis.

34

Future Direction of the Research
There is much work that can be done to build upon our hypothesis of chargemediated OxGPC formation. We do not know how the amine groups of the BPEI coating
plays a role in lipid peroxidation and how different positively-charged functionalities
would affect lipid peroxidation. The future direction of this research is focused on two
avenues, which both have to do with further investigating our hypothesized pathway of
PAF-like lipid synthesis (Figure 12). The first avenue deals with the positive NPs causing
PAF-like lipid formation. We will be conducting the same exposure scenario we show here
with cationic and anionic polystyrene NPs, which hold no toxic potential. Eliminating the
variable of Ag-ion toxicity will allow us a clearer idea on the ability of NP surface charge
to cause PAF-like lipid formation because PAFR activation could also have been due to
indirect PAF-like lipid formation. This would begin with ROS-mediated PAF-like lipid
formation through lipid peroxidation and subsequent IL-8 secretion. To confirm this, IL-8
secretion would need to be measured 2-hour post-exposure to Ag-NPs to identify whether
significant levels were present. Additionally, measuring IL-8 secretion after a NAC and
NP co-exposure would give us further support on the role of ROS during our hypothesized
synthesis pathway. The second avenue that we will focus on is the measuring of lipid
peroxidation with a flurometric assay kit (Abcam; ab118970). This will give us a direct
measurement of the extent of lipid peroxidation occurring during NP exposure.
Looking at much earlier timepoints (30 minute) also may be more valuable than
looking at a 24-hour exposure, since lipid peroxidation could occur quickly after charged35

NP exposure. Furthermore, utilizing even smaller NPs (5-10nm) would allow for more
physiologically practical application to remotely induce inflammation in intact skin.
TEM samples for KBM and KBP cells are on grids and ready to be imaged. The
same will be done for HaCaT cells to show internalization and localization at 8 hours postexposure. Energy-dispersive x-ray spectroscopy will also be performed to confirm that the
internalized metals are, in fact, Ag.
Further confocal images of KBM, KBP and HaCaT cells will also be carried out to
determine whether there is an increased expression of PAFR in cells exposed to charged
Ag-NPs and polystyrene NPs. Image J will be used to count fluorescence of the PAFR and
be compared to the control to quantify expression.
Most interestingly, there is also the matter of the anti-inflammatory effect of
charged-NPs that we displayed, which has been previously reported (Tomita, 2011).
Carrying out 100nM CPAF exposure with 10µg/mL charged Ag-NPs and polystyrene NPs
will also be carried out and inflammatory markers will be assessed. If charged NPs are able
to cause a PAFR-mediated anti-inflammatory effect, it would support in vivo work done in
mice that showed improved cognitive ability and reduced neuroinflammation of PAFRKO mice that received traumatic brain injury (Xiang, 2017).
There is great use for the KB model system in an air-liquid interface (ALI) model
as well. Culturing KBM or KBP cells in the apical compartment of the ALI culture and
macrophages or neutrophils in the basal compartment of the ALI culture, will allow us to
measure the chemotactic potential of NP exposure. We would do this by measuring apical
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and basal compartment immune cell concentration in a control well and compare them with
an exposed well to measure immune cell recruitment from the basal compartment into the
apical compartment. This could serve to advance the KB-PAFR model system by adding
an immune component to it. It would also be interesting to determine the effect of substrate
stiffness on PAFR activation, PAF-like lipid formation and NP uptake dynamics in KBM,
KBP and HaCaT cells.
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